Mechanisms of Cardioprotection by Volatile Anesthetics

Anesthesiology

Volumn 100, Issue 3, 2004, Pages 707-721

  Tanaka, Katsuya ^a   Ludwig, Lynda M ^a   Kersten, Judy R ^a   Pagel, Paul S ^a,b   Warltier, David C ^a,b,c  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Medical College of Wisconsin and Marquette University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,4,4A,5,12,12AALPHA OCTAHYDRO 4AALPHA (3 HYDROXYPHENYL) 2 METHYLQUINOLINO[2,3 G]ISOQUINOLINE; 4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 HYDROXYBENZYL] N,N DIETHYLBENZAMIDE; 5 HYDROXYDECANOIC ACID; 8 (4 SULFOPHENYL)THEOPHYLLINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE TRIPHOSPHATE; CARBOCROMEN; CLAMIKALANT; CYTOKINE; DESFLURANE; DIPYRIDAMOLE; ENFLURANE; GLIBENCLAMIDE; HALOTHANE; INHALATION ANESTHETIC AGENT; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; ISOFLURANE; LACTIC ACID; LAVENDUSTIN A; NICORANDIL; NITRIC OXIDE; OXYGEN; PINACIDIL; POTASSIUM CHANNEL; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; SEVOFLURANE; SULFONYLUREA RECEPTOR; UNINDEXED DRUG;

ARTERY PERFUSION; CONFERENCE PAPER; CORONARY ARTERY BLOOD FLOW; HEART; HEART INFARCTION; HEART MUSCLE METABOLISM; HEART PROTECTION; HEMODYNAMICS; HUMAN; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANESTHETICS, INHALATION; ANIMALS; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MEMBRANE PROTEINS; MYOCARDIAL ISCHEMIA; POTASSIUM CHANNELS; PROTEIN KINASES; REACTIVE OXYGEN SPECIES; RECEPTORS, G-PROTEIN-COUPLED;

EID: 1442283719     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200403000-00035     Document Type: Conference Paper

References (262)

1. Bland JH, Lowenstein E: Halothane-induced decrease in experimental myocardial ischemia in the non-failing canine heart. ANESTHESIOLOGY 1976; 45:287-93
2. Davis RF, DeBoer LW, Rude RE, Lowenstein E, Maroko PR: The effect of halothane anesthesia on myocardial necrosis, hemodynamic performance, and regional myocardial blood flow in dogs following coronary artery occlusion. ANESTHESIOLOGY 1983; 59:402-11
3. van Ackern K, Vetter HO, Bruckner UB, Madler C, Mittman U, Peter K: Effects of enflurane on myocardial ischaemia in the dog. Br J Anaesth 1985; 57:497-504
4. Warltier DC, Kersten JR, Pagel PS, Gross GJ: Anesthetic preconditioning: Serendipity and science (editorial). ANESTHESIOLOGY 2002; 97:1-3
5. Reiz S, Balfors E, Sorensen MB, Ariola S Jr, Friedman A, Truedsson H: Isoflurane: A powerful coronary vasodilator in patients with coronary artery disease. ANESTHESIOLOGY 1983; 59:91-7
6. Becker LC: Is isoflurane dangerous for the patient with coronary artery disease? ANESTHESIOLOGY 1987; 66:259-61
7. Buffington CW, Romson JL, Levine A, Duttlinger NC, Huang AH: Isoflurane induces coronary steal in a canine model of chronic coronary occlusion. ANESTHESIOLOGY 1987; 66:280-92
8. Priebe HJ, Foex P: Isoflurane causes regional myocardial dysfunction in dogs with critical coronary artery stenoses. ANESTHESIOLOGY 1987; 66:293-300
9. Gross GJ, Warltier DC: Coronary steal in four models of single or multiple vessel obstruction in dogs. Am J Cardiol 1981; 48:84-92
10. Warltier DC, Gross GJ, Brooks HL: Coronary steal-induced increase in myocardial infarct size after pharmacologic coronary vasodilation. Am J Cardiol 1980; 46:83-90
11. Becker LC: Conditions for vasodilator-induced coronary steal in experimental myocardial ischemia. Circulation 1978; 57:1103-10
12. Sill JC, Bove AA, Nugent M, Blaise GA, Dewey JD, Grabau C: Effects of isoflurane on coronary arteries and coronary arterioles in the intact dog. ANESTHESIOLOGY 1987; 66:273-9
13. Buffington CW, Davis KB, Gillispie S, Pettinger M: The prevalence of steal-prone coronary anatomy in patients with coronary artery disease: An analysis of the Coronary Artery Surgery Study Registry. ANESTHESIOLOGY 1988; 69:721-7
14. Moore PG, Kien ND, Reitan JA, White DA, Safwat AM: No evidence for blood flow redistribution with isoflurane or halothane during acute coronary artery occlusion in fentanyl-anesthetized dogs. ANESTHESIOLOGY 1991; 75:854-65
15. Hartman JC, Kampine JP, Schmeling WT, Warltier DC: Steal-prone coronary circulation in chronically instrumented dogs: Isoflurane versus adenosine. ANESTHESIOLOGY 1991; 74:744-56
16. Hartman JC, Kampine JP, Schmeling WT, Warltier DC: Actions of isoflurane on myocardial perfusion in chronically instrumented dogs with poor, moderate, or well-developed coronary collaterals. J Cardiothorac Anesth 1990; 4:715-25
17. Hartman JC, Kampine JP, Schmeling WT, Warltier DC: Alterations in collateral blood flow produced by isoflurane in a chronically instrumented canine model of multivessel coronary artery disease. ANESTHESIOLOGY 1991; 74:120-33
18. Leung JM, Goehner P, O'Kelly BF, Hollenberg M, Pineda N, Cason BA, Mangano DT: Isoflurane anesthesia and myocardial ischemia: Comparative risk versus sufentanil anesthesia in patients undergoing coronary artery bypass graft surgery. The SPI (Study of Perioperative Ischemia) Research Group. ANESTHESIOLOGY 1991; 74:838-47
19. Pulley DD, Kirvassilis GV, Kelermenos N, Kater K, Barzilai B, Genton RE, Efstathiou C, Lappas DG: Regional and global myocardial circulatory and metabolic effects of isoflurane and halothane in patients with steal-prone coronary anatomy. ANESTHESIOLOGY 1991; 75:756-66
20. Diana P, Tullock WC, Gorcsan J III, Ferson PF, Arvan S: Myocardial ischemia: A comparison between isoflurane and enflurane in coronary artery bypass patients. Anesth Analg 1993; 77:221-6
21. Kersten JR, Brayer AP, Pagel PS, Tessmer JP, Warltier DC: Perfusion of ischemic myocardium during anesthesia with sevoflurane. ANESTHESIOLOGY 1994; 81:995-1004
22. Kitahata H, Kawahito S, Nozaki J, Kimura H, Tanaka K, Kitagawa T, Oshita S: Effects of sevoflurane on regional myocardial blood flow distribution: Quantification with myocardial contrast echocardiography. ANESTHESIOLOGY 1999; 90: 1436-45
23. Hartman JC, Pagel PS, Kampine JP, Schmeling WT, Warltier DC: Influence of desflurane on regional distribution of coronary blood flow in a chronically instrumented canine model of multivessel coronary artery obstruction. Anesth Analg 1991; 72:289-99
24. Kenny D, Coughlan MG, Kampine JP, Montgomery RR, Bosnjak ZJ, Warltier DC: Cultured endothelial cells restore vasodilator responses to coronary arteries with impaired endothelial function and alter the response to a nitric oxide donor. Pharmacology 1994; 49:249-56
25. Lochner A, Harper IS, Salie R, Genade S, Coetzee AR: Halothane protects the isolated rat myocardium against excessive total intracellular calcium and structural damage during ischemia and reperfusion. Anesth Analg 1994; 79: 226-33
26. Schlack W, Preckel B, Stunneck D, Thamer V: Effects of halothane, enflurane, isoflurane, sevoflurane and desflurane on myocardial reperfusion injury in the isolated rat heart. Br J Anaesth 1998; 81:913-9
27. Preckel B, Thamer V, Schlack W: Beneficial effects of sevoflurane and desflurane against myocardial reperfusion injury after cardioplegic arrest. Can J Anaesth 1999; 46:1076-81
28. Preckel B, Schlack W, Comfere T, Obal D, Barthel H, Thamer V: Effects of enflurane, isoflurane, sevoflurane and desflurane on reperfusion injury after regional myocardial ischaemia in the rabbit heart in vivo. Br J Anaesth 1998; 81:905-12
29. Ebel D, Preckel B, You A, Mullenheim J, Schlack W, Thamer V: Cardioprotection by sevoflurane against reperfusion injury after cardioplegic arrest in the rat is independent of three types of cardioplegia. Br J Anaesth 2002; 88: 828-35
30. Obal D, Preckel B, Scharbatke H, Mullenheim J, Hoterkes F, Thamer V, Schlack W: One MAC of sevoflurane provides protection against reperfusion injury in the rat heart in vivo. Br J Anaesth 2001; 87:905-11
31. 2+ loading in intact hearts. ANESTHESIOLOGY 2002; 96:125-33
32. Kanaya N, Fujita S: The effects of isoflurane on regional myocardial contractility and metabolism in "stunned" myocardium in acutely instrumented dogs. Anesth Analg 1994; 79:447-54
33. Pagel PS, Hettrick DA, Lowe D, Tessmer JP, Warltier DC: Desflurane and isoflurane exert modest beneficial actions on left ventricular diastolic function during myocardial ischemia in dogs. ANESTHESIOLOGY 1995; 83:1021-35
34. Cope DK, Impastato WK, Cohen NW, Downey JM: Volatile anesthetics protect the ischemic rabbit myocardium from infarction. ANESTHESIOLOGY 1997; 86:699-709
35. Marijic J, Stowe DF, Turner LA, Kampine JP, Bosnjak ZJ: Differential protective effects of halothane and isoflurane against hypoxic and reoxygenation injury in the isolated guinea pig heart. ANESTHESIOLOGY 1990; 73:976-83
36. Coetzee A, Brits W, Genade S, Lochner A: Halothane does have protective properties in the isolated ischemic rat heart. Anesth Analg 1991; 73:711-9
37. Coetzee A, Skein W, Genade S, Lochner A: Enflurane and isoflurane reduce reperfusion dysfunction in the isolated rat heart. Anesth Analg 1993; 76:602-8
38. Freedman BM, Hamm DP, Everson CT, Wechsler AS, Christian CM II: Enflurane enhances postischemic functional recovery in the isolated rat heart. ANESTHESIOLOGY 1985; 62:29-33
39. Novalija E, Fujita S, Kampine JP, Stowe DF: Sevoflurane mimics ischemic preconditioning effects on coronary flow and nitric oxide release in isolated hearts. ANESTHESIOLOGY 1999; 91:701-12
40. Warltier DC, al-Wathiqui MH, Kampine JP, Schmeling WT: Recovery of contractile function of stunned myocardium in chronically instrumented dogs is enhanced by halothane or isoflurane. ANESTHESIOLOGY 1988; 69:552-65
41. Kersten JR, Lowe D, Hettrick DA, Pagel PS, Gross GJ, Warltier DC: Glyburide, a KATP channel antagonist, attenuates the cardioprotective effects of isoflurane in stunned myocardium. Anesth Analg 1996; 83:27-33
42. ATP channels: Reduction of myocardial infarct size with an acute memory phase. ANESTHESIOLOGY 1997; 87: 361-70
43. Cason BA, Gamperl AK, Slocum RE, Hickey RF: Anesthetic-induced preconditioning: Previous administration of isoflurane decreases myocardial infarct size in rabbits. ANESTHESIOLOGY 1997; 87:1182-90
44. ATP channels and opioid receptors. ANESTHESIOLOGY 2003; 98:705-11
45. Maxwell MP, Hearse DJ, Yellon DM: Species variation in the coronary collateral circulation during regional myocardial ischaemia: A critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res 1987; 21:737-46
46. Kehl F, Krolikowski JG, Mraovic B, Pagel PS, Warltier DC, Kersten JR: Is isoflurane-induced preconditioning dose related? ANESTHESIOLOGY 2002; 96:675-80
47. ATP channels via multiple signaling pathways. ANESTHESIOLOGY 2002; 97:4-14
48. Toller WG, Kersten JR, Pagel PS, Hettrick DA, Warltier DC: Sevoflurane reduces myocardial infarct size and decreases the time threshold for ischemic preconditioning in dogs. ANESTHESIOLOGY 1999; 91:1437-46
49. Tanaka K, Ludwig LM, Krolikowski JG, Alcindor D, Pratt PF, Kersten JR, Pagel PS, Warltier DC: Isoflurane produces delayed preconditioning against myocardial ischemia and reperfusion injury: Role of cyclooxygenase-2. ANESTHESIOLOGY 2004; 100:525-31
50. de Klaver MJ, Buckingham MG, Rich GF: Isoflurane pretreatment has immediate and delayed protective effects against cytokine-induced injury in endothelial and vascular smooth muscle cells. ANESTHESIOLOGY 2003; 99:896-903
51. Mullenheim J, Ebel D, Bauer M, Otto F, Heinen A, Frassdorf J, Preckel B, Schlack W: Sevoflurane confers additional cardioprotection after ischemic late preconditioning in rabbits. ANESTHESIOLOGY 2003; 99:624-31
52. Cason BA, Shubayev I, Hickey RF: Blockade of adenosine triphosphate-sensitive potassium channels eliminates isoflurane-induced coronary artery vasodilation. ANESTHESIOLOGY 1994; 81:1245-55
53. Crystal GJ, Gurevicius J, Salem MR, Zhou X: Role of adenosine triphosphate-sensitive potassium channels in coronary vasodilation by halothane, isoflurane, and enflurane. ANESTHESIOLOGY 1997; 86:448-58
54. Zhou X, Abboud W, Manabat NC, Salem MR, Crystal GJ: Isoflurane-induced dilation of porcine coronary arterioles is mediated by ATP-sensitive potassium channels. ANESTHESIOLOGY 1998; 89:182-9
55. Crystal GJ, Zhou X, Gurevicius J, Czinn EA, Salem MR, Alam S, Piotrowski A, Hu G: Direct coronary vasomotor effects of sevoflurane and desflurane in in situ canine hearts. ANESTHESIOLOGY 2000; 92:1103-13
56. Kersten JR, Warltier DC: The coronary circulation, Anesthesia: Biologic Foundations. Edited by Yaksh TL, Lynch C III, Zapol WM, Maze M, Biebuyck JF, Saidman LJ. Philadelphia, Lippincott-Raven, 1997, pp 1169-92
57. Smith G, Rogers K, Thorburn J: Halothane improves the balance of oxygen supply to demand in acute experimental myocardial ischaemia. Br J Anaesth 1980; 52:577-83
58. Bertha BG, Folts JD, Nugent M, Rusy BF: Halothane, but not isoflurane or enflurane, protects against spontaneous and epinephrine-exacerbated acute thrombus formation in stenosed dog coronary arteries. ANESTHESIOLOGY 1989; 71:96-102
59. ATP channels in vivo. ANESTHESIOLOGY 1999; 90:246-56
60. Kowalski C, Zahler S, Becker BF, Flaucher A, Conzen PF, Gerlach E, Peter K: Halothane, isoflurane, and sevoflurane reduce postischemic adhesion of neutrophils in the coronary system. ANESTHESIOLOGY 1997; 86:188-95
61. de Klaver MJ, Manning L, Palmer LA, Rich GF: Isoflurane pretreatment inhibits cytokine-induced cell death in cultured rat smooth muscle cells and human endothelial cells. ANESTHESIOLOGY 2002; 97:24-32
62. Yvon A, Hanouz JL, Haelewyn B, Terrien X, Massetti M, Babatasi G, Khayat A, Ducouret P, Bricard H, Gerard JL: Mechanisms of sevoflurane-induced myocardial preconditioning in isolated human right atria in vitro. ANESTHESIOLOGY 2003; 99:27-33
63. Hanouz JL, Yvon A, Massetti M, Lepage O, Babatasi G, Khayat A, Bricard H, Gerard JL: Mechanisms of desflurane-induced preconditioning in isolated human right atria in vitro. ANESTHESIOLOGY 2002; 97:33-41
64. An J, Varadarajan SG, Novalija E, Stowe DF: Ischemic and anesthetic preconditioning reduces cytosolic [Ca2+] and improves Ca(2+) responses in intact hearts. Am J Physiol Heart Circ Physiol 2001; 281:H1508-23
65. Eskinder H, Rusch NJ, Supan FD, Kampine JP, Bosnjak ZJ: The effects of volatile anesthetics on L- and T-type calcium channel currents in canine cardiac Purkinje cells. ANESTHESIOLOGY 1991; 74:919-26
66. 2+ transients and papillary muscle tension in guinea pigs. ANESTHESIOLOGY 1992; 76:123-31
67. Lynch C III: Effects of halothane and isoflurane on isolated human ventricular myocardium. ANESTHESIOLOGY 1988; 68:429-32
68. Hatakeyama N, Momose Y, Ito Y: Effects of sevoflurane on contractile responses and electrophysiologic properties in canine single cardiac myocytes. ANESTHESIOLOGY 1995; 82:559-65
69. Roscoe AK, Christensen JD, Lynch C III: Isoflurane, but not halothane, induces protection of human myocardium via adenosine A1 receptors and adenosine triphosphate-sensitive potassium channels. ANESTHESIOLOGY 2000; 92: 1692-701
70. Kersten JR, Orth KG, Pagel PS, Mei DA, Gross GJ, Warltier DC: Role of adenosine in isoflurane-induced cardioprotection. ANESTHESIOLOGY 1997; 86:1128-39
71. Toller WG, Montgomery MW, Pagel PS, Hettrick DA, Warltier DC, Kersten JR: Isoflurane-enhanced recovery of canine stunned myocardium: Role for protein kinase C? ANESTHESIOLOGY 1999; 91:713-22
72. Ludwig LM, Weihrauch D, Kersten JR, Pagel PS, Warltier DC: Protein kinase C translocation and Src protein tyrosine kinase activation mediate isoflurane-induced preconditioning in vivo: Potential downstream targets of mitochondrial adenosine triphosphate-sensitive potassium channels and reactive oxygen species. ANESTHESIOLOGY 2004; 100:532-9
73. Toller WG, Kersten JR, Gross ER, Pagel PS, Warltier DC: Isoflurane preconditions myocardium against infarction via activation of inhibitory guanine nucleotide binding proteins. ANESTHESIOLOGY 2000; 92:1400-7
74. Mullenheim J, Ebel D, Frassdorf J, Preckel B, Thamer V, Schlack W: Isoflurane preconditions myocardium against infarction via release of free radicals. ANESTHESIOLOGY 2002; 96:934-40
75. Tanaka K, Weihrauch D, Kehl F, Ludwig LM, LaDisa JF Jr, Kersten JR, Pagel PS, Warltier DC: Mechanism of preconditioning by isoflurane in rabbits: A direct role for reactive oxygen species. ANESTHESIOLOGY 2002; 97:1485-90
76. Novalija E, Varadarajan SG, Camara AK, An J, Chen Q, Riess ML, Hogg N, Stowe DF: Anesthetic preconditioning: Triggering role of reactive oxygen and nitrogen species in isolated hearts. Am J Physiol Heart Circ Physiol 2002; 283: H44-52
77. Piriou V, Chiari P, Knezynski S, Bastien O, Loufoua J, Lehot JJ, Foex P, Annat G, Ovize M: Prevention of isoflurane-induced preconditioning by 5-hydroxydecanoate and gadolinium: Possible involvement of mitochondrial adenosine triphosphate-sensitive potassium and stretch-activated channels. ANESTHESIOLOGY 2000; 93:756-64
78. Toller WG, Gross ER, Kersten JR, Pagel PS, Gross GJ, Waritier DC: Sarcolemmal and mitochondrial adenosine triphosphate-dependent potassium channels: Mechanism of desflurane-induced cardioprotection. ANESTHESIOLOGY 2000; 92:1731-9
79. Ismaeil MS, Tkachenko I, Gamperl AK, Hickey RF, Cason BA: Mechanisms of isoflurane-induced myocardial preconditioning in rabbits. ANESTHESIOLOGY 1999; 90:812-21
80. Inagaki N, Gonoi T, Clement JP IV, Namba N, Inazawa J, Gonzalez G, Aguilar-Bryan L, Seino S, Bryan J: Reconstitution of IKATP: An inward rectifier subunit plus the sulfonylurea receptor. Science 1995; 270:1166-70
81. Noma A: ATP-regulated K+ channels in cardiac muscle. Nature 1983; 305:147-8
82. Inoue I, Nagase H, Kishi K, Higuti T: ATP-sensitive K+ channel in the mitochondrial inner membrane. Nature 1991; 352:244-7
83. Liu Y, Ren G, O'Rourke B, Marban E, Seharaseyon J: Pharmacological comparison of native mitochondrial K(ATP) channels with molecularly defined surface K(ATP) channels. Mol Pharmacol 2001; 59:225-30
84. Kersten JR, Gross GJ, Pagel PS, Warltier DC: Activation of adenosine triphosphate-regulated potassium channels: Mediation of cellular and organ protection. ANESTHESIOLOGY 1998; 88:495-513
85. Gross GJ, Auchampach JA: Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 1992; 70:223-33
86. O'Rourke B: Myocardial K(ATP) channels in preconditioning. Circ Res 2000; 87:845-55
87. ATP) channels ANESTHESIOLOGY 1996; 85:794-807
88. Nakayama M, Fujita S, Kanaya N, Tsuchida H, Namiki A: Blockade of ATP-sensitive K+ channel abolishes the anti-ischemic effects of isoflurane in dog hearts. Acta Anaesthesiol Scand 1997; 41:531-5
89. Kwok WM, Martinelli AT, Fujimoto K, Suzuki A, Stadnicka A, Bosnjak ZJ: Differential modulation of the cardiac adenosine triphosphate-sensitive potassium channel by isoflurane and halothane. ANESTHESIOLOGY 2002; 97:50-6
90. ATP channel. ANESTHESIOLOGY 2002; 97:57-65
91. Han J, Kim E, Ho WK, Earrn YE: Effects of volatile anesthetic isoflurane on ATP-sensitive K+ channels in rabbit ventricular myocytes. Biochem Biophys Res Commun 1996; 229:852-6
92. ATP channel. ANESTHESIOLOGY 2002; 97:1198-208
93. Gassmayr S, Stadnicka A, Suzuki A, Kwok WM, Bosnjak ZJ: Isoflurane sensitizes the cardiac sarcolemmal adenosine triphosphate-sensitive potassium channel to pinacidil. ANESTHESIOLOGY. 2003; 98:114-20
94. ATP channel at reduced intracellular pH. ANESTHESIOLOGY 2003; 98:396-403
95. Kohro S, Hogan QH, Nakae Y, Yamakage M, Bosnjak ZJ: Anesthetic effects on mitochondrial ATP-sensitive K channel. ANESTHESIOLOGY 2001; 95:1435-40
96. Hanley PJ, Mickel M, Loffler M, Brandt U, Daut J: K(ATP) channel-independent targets of diazoxide and 5-hydroxydecanoate in the heart. J Physiol 2002; 542:735-41
97. Nakae Y, Kwok WM, Bosnjak ZJ, Jiang MT: Isoflurane activates rat mitochondrial ATP-sensitive K+ channels reconstituted in lipid bilayers. Am J Physiol Heart Circ Physiol 2003; 284:H1865-71
98. Ichinari K, Kakei M, Matsuoka T, Nakashima H, Tanaka H: Direct activation of the ATP-sensitive potassium channel by oxygen free radicals in guinea-pig ventricular cells: Its potentiation by MgADP. J Mol Cell Cardiol 1996; 28:1867-77
99. Sasaki N, Sato T, Marban E, O'Rourke B: ATP consumption by uncoupled mitochondria activates sarcolemmal K(ATP) channels in cardiac myocytes. Am J Physiol Heart Circ Physiol 2001; 280:H1882-8
100. Daut J, Maier-Rudolph W, von Beckerath N, Mehrke G, Gunther K, Goedel-Meinen L: Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels. Science 1990; 247:1341-4
101. Kehl F, Krolikowski JG, Tessmer JP, Pagel PS, Warltier DC, Kersten JR: Increases in coronary collateral blood flow produced by sevoflurane are mediated by calcium-activated potassium (BKCa) channels in vivo. ANESTHESIOLOGY 2002; 97:725-31
102. Piriou V, Ross S, Bastien O, Pigott D, Trivin F, Foex P: Cardiovascular effects of concomitant administration of isoflurane and nicorandil in dogs. Br J Anaesth 1998; 80:481-7
103. Patel HH, Ludwig LM, Fryer RM, Hsu AK, Warltier DC, Gross GJ: Delta opioid agonists and volatile anesthetics facilitate cardioprotection via potentiation of K(ATP) channel opening. FASEB J 2002; 16:1468-70
104. Van Wylen DG: Effect of ischemic preconditioning on interstitial purine metabolite and lactate accumulation during myocardial ischemia. Circulation 1994; 89:2283-9
105. Mizumura T, Nithipatikom K, Gross GJ: Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs. Circulation 1995; 92:1236-45
106. Fryer RM, Wang Y, Hsu AK, Gross GJ: Essential activation of PKC-delta in opioid-initiated cardioprotection. Am J Physiol Heart Circ Physiol 2001; 280: H1346-53
107. Fryer RM, Hsu AK, Nagase H, Gross GJ: Opioid-induced cardioprotection against myocardial infarction and arrhythmias: Mitochondrial versus sarcolemmal ATP-sensitive potassium channels. J Pharmacol Exp Ther 2000; 294:451-7
108. Schultz Jel-J, Hsu AK, Nagase H, Gross GJ: TAN-67, a delta 1-opioid receptor agonist, reduces infarct size via activation of Gi/o proteins and KATP channels. Am J Physiol 1998; 274:H909-14
109. Patel HH, Hsu A, Moore J, Gross GJ: BW373U86, a delta opioid agonist, partially mediates delayed cardioprotection via a free radical mechanism that is independent of opioid receptor stimulation. J Mol Cell Cardiol 2001; 33:1455-65
110. Fryer RM, Hsu AK, Eells JT, Nagase H, Gross GJ: Opioid-induced second window of cardioprotection: Potential role of mitochondrial KATP channels. Circ Res 1999; 84:846-51
111. McPherson BC, Yao Z: Morphine mimics preconditioning via free radical signals and mitochondrial K(ATP) channels in myocytes. Circulation 2001; 103: 290-5
112. Liang BT, Gross GJ: Direct preconditioning of cardiac myocytes via opioid receptors and KATP channels. Circ Res 1999; 84:1396-400
113. Schultz JE, Hsu AK, Gross GJ: Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res 1996; 78:1100-4
114. Schultz JE, Hsu AK, Gross GJ: Ischemic preconditioning in the intact rat heart is mediated by deltal- but not mu- or kappa-opioid receptors. Circulation 1998; 97:1282-9
115. Ishizawa Y, Pidikiti R, Liebman PA, Eckenhoff RG: G protein-coupled receptors as direct targets of inhaled anesthetics. Mol Pharmacol 2002; 61: 945-52
116. Fryer RM, Schultz JE, Hsu AK. Gross GJ: Importance of PKC and tyrosine kinase in single or multiple cycles of preconditioning in rat hearts. Am J Physiol Heart Circ Physiol 1999; 276:H1229-35
117. Fryer RM, Patel HH, Hsu AK, Gross GJ: Stress-activated protein kinase phosphorylation during cardioprotection in the ischemic myocardium. Am J Physiol Heart Circ Physiol 2001; 281:H1184-92
118. Fryer RM, Pratt PF, Hsu AK, Gross GJ: Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardioprotection. J Pharmacol Exp Ther 2001; 296:642-9
119. Liu H, McPherson BC, Yao Z: Preconditioning attenuates apoptosis and necrosis: Role of protein kinase C epsilon and -delta isoforms. Am J Physiol Heart Circ Physiol 2001; 281:H404-10
120. Puceat M, Vassort G: Signalling by protein kinase C isoforms in the heart. Mol Cell Biochem 1996; 157:65-72
121. Liu GS, Thornton J, Van Winkle DM, Stanley AW, Olsson RA, Downey JM: Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 1991; 84:350-6
122. Tsuchida A, Miura T, Miki T, Shimamoto K, Iimura O: Role of adenosine receptor activation in myocardial infarct size limitation by ischaemic preconditioning. Cardiovasc Res 1992; 26:456-61
123. Wall TM, Sheehy R, Hartman JC: Role of bradykinin in myocardial preconditioning. J Pharmacol Exp Ther 1994; 270:681-9
124. Goto M, Liu Y, Yang XM, Ardell JL, Cohen MV, Downey JM: Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 1995; 77:611-21
125. Schultz JE, Rose E, Yao Z, Gross GJ: Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol Heart Circ Physiol 1995; 268:H2157-61
126. Schultz JJ, Hsu AK, Gross GJ: Ischemic preconditioning and morphine-induced cardioprotection involve the delta (delta)-opioid receptor in the intact rat heart. J Mol Cell Cardiol 1997; 29:2187-95
127. Hemmings HC Jr, Adamo AI: Activation of endogenous protein kinase C by halothane in synaptosomes. ANESTHESIOLOGY 1996; 84:652-62
128. Hemmings HC Jr: General anesthetic effects on protein kinase C. Toxicol Lett 1998; 100-101:89-95
129. Uecker M, da Silva R, Grampp T, Pasch T, Schaub MC, Zaugg M: Translocation of protein kinase C isoforms to subcellular targets in ischemic and anesthetic preconditioning. ANESTHESIOLOGY 2003; 99:138-47
130. Ismaeil MS, Tkachenko I, Hickey RF, Cason BA: Colchicine inhibits isoflurane-induced preconditioning. ANESTHESIOLOGY 1999; 91:1816-22
131. Sato T, O'Rourke B, Marban E: Modulation of mitochondrial ATP-dependent K+ channels by protein kinase C. Circ Res 1998; 83:110-4
132. Hu K, Duan D, Li GR, Nattel S: Protein kinase C activates ATP-sensitive K+ current in human and rabbit ventricular myocytes. Circ Res 1996; 78:492-8
133. Liu Y, Gao WD, O'Rourke B, Marban E: Synergistic modulation of ATP-sensitive K+ currents by protein kinase C and adenosine: Implications for ischemic preconditioning. Circ Res 1996; 78:443-54
134. Sato T, Sasaki N, O'Rourke B, Marban E: Adenosine primes the opening of mitochondrial ATP-sensitive potassium channels: A key step in ischemic preconditioning? Circulation 2000; 102:800-5
135. Light PE, Bladen C, Winkfein RJ, Walsh MP, French RJ: Molecular basis of protein kinase C-induced activation of ATP-sensitive potassium channels. Proc Natl Acad Sci U S A 2000; 97:9058-63
136. Ohnuma Y, Miura T, Miki T, Tanno M, Kuno A, Tsuchida A, Shimamoto K: Opening of mitochondrial K(ATP) channel occurs downstream of PKC-epsilon activation in the mechanism of preconditioning. Am J Physiol Heart Circ Physiol 2002; 283:H440-7
137. Baines CP, Wang L, Cohen MV, Downey JM: Protein tyrosine kinase is downstream of protein kinase C for ischemic preconditioning's anti-infarct effect in the rabbit heart. J Mol Cell Cardiol 1998; 30:383-92
138. Ping P, Zhang J, Zheng YT, Li RC, Dawn B, Tang XL, Takano H, Balafanova Z, Bolli R: Demonstration of selective protein kinase C-dependent activation of Src and Lck tyrosine kinases during ischemic preconditioning in conscious rabbits. Circ Res 1999; 85:542-50
139. Ping P, Zhang J, Cao X, Li RC, Kong D, Tang XL, Qiu Y, Manchikalapudi S, Auchampach JA, Black RG, Bolli R: PKC-dependent activation of p44/p42 MAPKs during myocardial ischemia-reperfusion in conscious rabbits. Am J Physiol Heart Circ Physiol 1999; 276:H1468-81
140. Ytrehus K, Liu Y, Downey JM: Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol Heart Circ Physiol 1994; 266:H1145-52
141. Tanno M, Tsuchida A, Nozawa Y, Matsumoto T, Hasegawa T, Miura T, Shimamoto K: Roles of tyrosine kinase and protein kinase C in infarct size limitation by repetitive ischemic preconditioning in the rat. J Cardiovasc Pharmacol 2000; 35:345-52
142. Hattori R, Otani H, Uchiyama T, Imamura H, Cui J, Maulik N, Cordis GA, Zhu L, Das DK: Src tyrosine kinase is the trigger but not the mediator of ischemic preconditioning. Am J Physiol Heart Circ Physiol 2001; 281:H1066-74
143. Fryer RM, Hsu AK, Gross GJ: ERK and p38 MAP kinase activation are components of opioid-induced delayed cardioprotection. Basic Res Cardiol 2001; 96:136-42
144. Sanada S, Kitakaze M, Papst PJ, Hatanaka K, Asanuma H, Aki T, Shinozaki Y, Ogita H, Node K, Takashima S, Asakura M, Yamada J, Fukushima T, Ogai A, Kuzuya T, Mori H, Terada N, Yoshida K, Hori M: Role of phasic dynamism of p38 mitogen-activated protein kinase activation in ischemic preconditioning of the canine heart. Circ Res 2001; 88:175-80
145. Mocanu MM, Baxter GF, Yue Y, Critz SD, Yellon DM: The p38 MAPK inhibitor, SB203580, abrogates ischemic preconditioning in rat heart but timing of administration is critical. Basic Res Cardiol 2000; 95:472-8
146. Canman CE, Kastan MB: Signal transduction: Three paths to stress relief. Nature 1996; 384:213-4
147. Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K, Gotoh Y: Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 1997; 275:90-4
148. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995; 270:1326-31
149. da Silva R, Grampp T, Pasch T, Schaub MC, Zaugg M: Differential activation of mitogen-activated protein kinases in ischemic and anesthetic preconditioning. ANESTHESIOLOGY 2004; 100:59-69
150. Zweier JL, Flaherty JT, Weisfeldt ML: Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci U S A 1987; 84:1404-7
151. Bolli R, Patel BS, Jeroudi MO, Lai EK, McCay PB: Demonstration of free radical generation in "stunned" myocardium of intact dogs with the use of the spin trap alpha-phenyl N-tert-butyl nitrone. J Clin Invest 1988; 82:476-85
152. Ambrosio G, Zweier JL, Duilio C, Kuppusamy P, Santoro G, Elia PP, Tritto I, Cirillo P, Condorelli M, Chiariello M: Evidence that mitochondrial respiration is a source of potentially toxic oxygen free radicals in intact rabbit hearts subjected to ischemia and reflow. J Biol Chem 1993; 268:18532-41
153. Tanguay M, Blaise G, Dumont L, Beique G, Hollmann C: Beneficial effects of volatile anesthetics on decrease in coronary flow and myocardial contractility induced by oxygen-derived free radicals in isolated rabbit hearts. J Cardiovasc Pharmacol 1991; 18:863-70
154. Nakamura T, Kashimoto S, Oguchi T, Kumazawa T: Hydroxyl radical formation during inhalation anesthesia in the reperfused working rat heart. Can J Anaesth 1999; 46:470-5
155. Glantz L, Ginosar Y, Chevion M, Gozal Y, Elami A, Navot N, Kitrossky N, Drenger B: Halothane prevents postischemic production of hydroxyl radicals in the canine heart. ANESTHESIOLOGY 1997; 86:440-7
156. Hu G, Vinten-Johansen J, Salem MR, Zhao ZQ, Crystal GJ: Isoflurane inhibits neutrophil-endothelium interactions in the coronary circulation: Lack of a role for adenosine triphosphate-sensitive potassium channels. Anesth Analg 2002; 94:849-56
157. Hu G, Vasiliauskas T, Salem MR, Rhone DP, Crystal GJ: Neutrophils pretreated with volatile anesthetics lose ability to cause cardiac dysfunction. ANESTHESIOLOGY 2003; 98:712-8
158. Ambrosio G, Tritto I, Chiariello M: The role of oxygen free radicals in preconditioning. J Mol Cell Cardiol 1995; 27:1035-9
159. Tritto I, D'Andrea D, Eramo N, Scognamiglio A, De Simone C, Violante A, Esposito A, Chiariello M, Ambrosio G: Oxygen radicals can induce preconditioning in rabbit hearts. Circ Res 1997; 80:743-8
160. Vanden Hoek TL, Becker LB, Shao Z, Li C, Schumacker PT: Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J Biol Chem 1998; 273:18092-8
161. Baines CP, Goto M, Downey JM: Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Mol Cell Cardiol 1997; 29:207-16
162. Tanaka M, Fujiwara H, Yamasaki K, Sasayama S: Superoxide dismutase and N-2-mercaptopropionyl glycine attenuate infarct size limitation effect of ischaemic preconditioning in the rabbit. Cardiovasc Res 1994; 28:980-6
163. Pain T, Yang XM, Critz SD, Yue Y, Nakano A, Liu GS. Heusch G, Cohen MV, Downey JM: Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals. Circ Res 2000; 87:460-6
164. Droge W: Free radicals in the physiological control of cell function. Physiol Rev 2002; 82:47-95
165. Clerk A, Michael A, Sugden PH: Stimulation of multiple mitogen-activated protein kinase sub-families by oxidative stress and phosphorylation of the small heat shock protein, HSP25/27, in neonatal ventricular myocytes. Biochem J 1998; 333:581-9
166. Samavati L, Monick MM, Sanlioglu S, Buettner GR, Oberley LW, Hunninghake GW: Mitochondrial K(ATP) channel openers activate the ERK kinase by an oxidant-dependent mechanism. Am J Physiol Cell Physiol 2002; 283:C273-81
167. Kulisz A, Chen N, Chandel NS, Shao Z, Schumacker PT: Mitochondrial ROS initiate phosphorylation of p38 MAP kinase during hypoxia in cardiomyocytes. Am J Physiol Lung Cell Mol Physiol 2002; 282:L1324-9
168. Nishida M, Maruyama Y, Tanaka R, Kontani K, Nagao T, Kurose H: G alpha(i) and G alpha(o) are target proteins of reactive oxygen species. Nature 2000; 408:492-5
169. Nishida M, Schey KL, Takagahara S, Kontani K, Katada T, Urano Y, Nagano T, Nagao T, Kurose H: Activation mechanism of Gi and Go by reactive oxygen species. J Biol Chem 2002; 277:9036-42
170. Novalija E, Kevin LG, Camara AK, Bosnjak ZJ, Kampine JP, Stowe DF: Reactive oxygen species precede the epsilon isoform of protein kinase C in the anesthetic preconditioning signaling cascade. ANESTHESIOLOGY 2003; 99:421-8
171. Patel HH, Gross GJ: Diazoxide induced cardioprotection: What comes first, K(ATP) channels or reactive oxygen species? Cardiovasc Res 2001; 51: 633-6
172. Carroll R, Gant VA, Yellon DM: Mitochondrial K(ATP) channel opening protects a human atrial-derived cell line by a mechanism involving free radical generation. Cardiovasc Res 2001; 51:691-700
173. Forbes RA, Steenbergen C, Murphy E: Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism. Circ Res 2001; 88:802-9
174. Zhang DX, Chen YF, Campbell WB, Zou AP, Gross GJ, Li PL: Characteristics and superoxide-induced activation of reconstituted myocardial mitochondrial ATP-sensitive potassium channels. Circ Res 2001; 89:1177-83
175. Lebuffe G, Schumacker PT, Shao ZH, Anderson T, Iwase H, Vanden Hoek TL: ROS and NO trigger early preconditioning: Relationship to mitochondrial KATP channel. Am J Physiol Heart Circ Physiol 2003; 284:H299-308
176. Gross GJ, Fryer RM: Mitochondrial K(ATP) channels: Triggers or distal effectors of ischemic or pharmacological preconditioning? Circ Res 2000; 87: 431-3
177. Tanaka K, Weihrauch D, Ludwig LM, Kersten JR, Pagel PS, Warltier DC: Mitochondrial adenosine triphosphate-regulated potassium channel opening acts as a trigger for isoflurane-induced preconditioning by generating reactive oxygen species. ANESTHESIOLOGY 2003; 98:935-43
178. Kevin LG, Novalija E, Riess ML, Camara AK, Rhodes SS, Stowe DF: Sevoflurane exposure generates superoxide but leads to decreased superoxide during ischemia and reperfusion in isolated hearts. Anesth Analg 2003; 96: 949-55
179. Yao Z, Tong J, Tan X, Li C, Shao Z, Kim WC, vanden Hoek TL, Becker LB, Head CA, Schumacker PT: Role of reactive oxygen species in acetylcholine-induced preconditioning in cardiomyocytes. Am J Physiol Heart Circ Physiol 1999; 277:H2504-9
180. Vanden Hoek TL, Shao Z, Li C, Schumacker PT, Becker LB: Mitochondrial electron transport can become a significant source of oxidative injury in cardiomyocytes. J Mol Cell Cardiol 1997; 29:2441-50
181. Hanley PJ, Ray J, Brandt U, Daut J: Halothane, isoflurane and sevoflurane inhibit NADH:ubiquinone oxidoreductase (complex I) of cardiac mitochondria. J Physiol 2002; 544:687-93
182. Riess ML, Stowe DF, Henry MM, Camara AK, Eells JT, Kevin LG: Concentration dependent attenuation of mitochondrial respiration by sevoflurane in isolated cardiac mitochondria is mediated in part by reactive oxygen species (on-line abstract available at: www.anesthesiology.org). ANESTHESIOLOGY 2003; 99:A1556
183. Tanaka K, Ludwig LM, Kersten JR, Pagel PS, Warltier DC: Reactive oxygen species released from mitochondrial electron transport chain complex III are involved in isoflurane-induced preconditioning in vivo (on-line abstract available at: www.anesthesiology.org). ANESTHESIOLOGY 2003; 99:A735
184. Mohazzab KM, Kaminski PM, Wolin MS: NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol Heart Circ Physiol 1994; 266:H2568-72
185. Xia Y, Zweier JL: Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci U S A 1997; 94:6954-8
186. Turrens JF: Superoxide production by the mitochondrial respiratory chain. Biosci Rep 1997; 17:3-8
187. Cai H, Harrison DG: Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circ Res 2000; 87:840-4
188. Abe J, Berk BC: Reactive oxygen species as mediators of signal transduction in cardiovascular disease. Trends Cardiovasc Med 1998; 8:59-64
189. Wang XT, McCullough KD, Wang XJ, Carpenter G, Holbrook NJ: Oxidative stress-induced phospholipase C-gamma 1 activation enhances cell survival. J Biol Chem 2001; 276:28364-71
190. Maulik N, Watanabe M, Zu YL, Huang CK, Cordis GA, Schley JA, Das DK: Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBS Lett 1996; 396:233-7
191. Aikawa R, Komuro I, Yamazaki T, Zou Y, Kudoh S, Tanaka M, Shiojima I, Hiroi Y, Yazaki Y: Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. J Clin Invest 1997; 100:1813-21
192. Dabrowski A, Boguslowicz C, Dabrowska M, Tribillo I, Gabryelewicz A: Reactive oxygen species activate mitogen-activated protein kinases in pancreatic acinar cells. Pancreas 2000; 21:376-84
193. Carter WO, Narayanan PK, Robinson JP: Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells. J Leukoc Biol 1994; 55: 253-8
194. Cuzzocrea S, Riley DP, Caputi AP, Salvemini D: Antioxidant therapy: A new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 2001; 53:135-59
195. Liu Y, Gutterman DD: Oxidative stress and potassium channel function. Clin Exp Pharmacol Physiol 2002; 29:305-11
196. Nichols CG, Lederer WJ: The regulation of ATP-sensitive K+ channel activity in intact and permeabilized rat ventricular myocytes. J Physiol 1990; 423:91-110
197. Yao Z, Gross GJ: Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs. Circulation 1994; 89:1769-75
198. Munch-Ellingsen J, Lokebo JE, Bugge E, Jonassen AK, Ravingerova T, Ytrehus K: 5-HD abolishes ischemic preconditioning independently of monophasic action potential duration in the heart. Basic Res Cardiol 2000; 95:228-34
199. Hamada K, Yamazaki J, Nagao T: Shortening of action potential duration is not prerequisite for cardiac protection by ischemic preconditioning or a KATP channel opener. J Mol Cell Cardiol 1998; 30:1369-79
200. Suzuki M, Sasaki N, Miki T, Sakamoto N, Ohmoto-Sekine Y, Tamagawa M, Seino S, Marban E, Nakaya H: Role of sarcolemmal K(ATP) channels in cardioprotection against ischemia/reperfusion injury in mice. J Clin Invest 2002; 109: 509-16
201. Dos Santos P, Kowaltowski AJ, Laclau MN, Seetharaman S, Paucek P, Boudina S, Thambo JB, Tariosse L, Garlid KD: Mechanisms by which opening the mitochondrial ATP-sensitive K(+) channel protects the ischemic heart. Am J Physiol Heart Circ Physiol 2002; 283:H284-95
202. Dzeja PP, Holmuhamedov EL, Ozcan C, Pucar D, Jahangir A, Terzic A: Mitochondria: Gateway for cytoprotection. Circ Res 2001; 89:744-6
203. Holmuhamedov EL, Wang L, Terzic A: ATP-sensitive K+ channel openers prevent Ca2+ overload in rat cardiac mitochondria. J Physiol 1999; 519:347-60
204. Holmuhamedov EL, Jovanovic S, Dzeja PP, Jovanovic A, Terzic A: Mitochondrial ATP-sensitive K+ channels modulate cardiac mitochondrial function. Am J Physiol Heart Circ Physiol 1998; 275:H1567-76
205. Minners J, Lacerda L, McCarthy J, Meiring JJ, Yellon DM, Sack MN: Ischemic and pharmacological preconditioning in Girardi cells and C2C12 myotubes induce mitochondrial uncoupling. Circ Res 2001; 89:787-92
206. Halestrap AP: The regulation of the matrix volume of mammalian mitochondria in vivo and in vitro and its role in the control of mitochondrial metabolism. Biochim Biophys Acta 1989; 973:355-82
207. Garlid KD: Cation transport in mitochondria: The potassium cycle. Biochim Biophys Acta 1996; 1275:123-6
208. Garlid KD: On the mechanism of regulation of the mitochondrial K+/H+ exchanger. J Biol Chem 1980; 255:11273-9
209. Green DR, Reed JC: Mitochondria and apoptosis. Science 1998; 281: 1309-12
210. Akao M, Ohler A, O'Rourke B, Marban E: Mitochondrial ATP-sensitive potassium channels inhibit apoptosis induced by oxidative stress in cardiac cells. Circ Res 2001; 88:1267-75
211. Ozcan C, Bienengraeber M, Dzeja PP, Terzic A: Potassium channel openers protect cardiac mitochondria by attenuating oxidant stress at reoxygenation. Am J Physiol Heart Circ Physiol 2002; 282:H531-9
212. Fryer RM, Eells JT, Hsu AK, Henry MM, Gross GJ: Ischemic preconditioning in rats: Role of mitochondrial K(ATP) channel in preservation of mitochondrial function. Am J Physiol Heart Circ Physiol 2000; 278:H305-12
213. Tanonaka K, Taguchi T, Koshimizu M, Ando T, Morinaka T, Yogo T, Konishi F, Takeo S: Role of an ATP-sensitive potassium channel opener, YM934, in mitochondrial energy production in ischemic/reperfused heart. J Pharmacol Exp Ther 1999; 291:710-6
214. Novalija E, Kevin LG, Eells JT, Henry MM, Stowe DF: Anesthetic preconditioning improves adenosine triphosphate synthesis and reduces reactive oxygen species formation in mitochondria after ischemia by a redox dependent mechanism. ANESTHESIOLOGY 2003; 98:1155-63
215. Riess ML, Novalija E, Camara AK, Eells JT, Chen Q, Stowe DF: Preconditioning with sevoflurane reduces changes in nicotinamide adenine dinucleotide during ischemia-reperfusion in isolated hearts: Reversal by 5-hydroxydecanoic acid. ANESTHESIOLOGY 2003; 98:387-95
216. Zorov DB, Filburn CR, Klotz LO, Zweier JL, Sollott SJ: Reactive oxygen species (ROS)-induced ROS release: A new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med 2000; 192:1001-14
217. Kroemer G, Reed JC: Mitochondrial control of cell death. Nat Med 2000; 6:513-9
218. Kowaltowski AJ, Castilho RF, Vercesi AE: Mitochondrial permeability transition and oxidative stress. FEBS Lett 2001; 495:12-5
219. Hausenloy DJ, Maddock HL, Baxter GF, Yellon DM: Inhibiting mitochondrial permeability transition pore opening: A new paradigm for myocardial preconditioning? Cardiovasc Res 2002; 55:534-43
220. Piriou V, Chiari P, Roesch OG, Lehot JJ, Ovize M: Effect of desflurane-induced preconditioning on mitochondrial transition pore opening (on-line abstract available at: www.anesthesiology.org). ANESTHESIOLOGY 2003; 99:A1538
221. Allard MF, Flint JD, English JC, Henning SL, Salamanca MC, Kamimura CT, English DR: Calcium overload during reperfusion is accelerated in isolated hypertrophied rat hearts. J Mol Cell Cardiol 1994; 26:1551-63
222. Miyamae M, Camacho SA, Weiner MW, Figueredo VM: Attenuation of postischemic reperfusion injury is related to prevention of [Ca2+]m overload in rat hearts. Am J Physiol Heart Circ Physiol 1996; 271:H2145-53
223. Di Lisa F, Bernardi P: Mitochondrial function as a determinant of recovery or death in cell response to injury. Mol Cell Biochem 1998; 184:379-91
224. Wang L, Cherednichenko G, Hernandez L, Halow J, Camacho SA, Figueredo V, Schaefer S: Preconditioning limits mitochondrial Ca(2+) during ischemia in rat hearts: Role of K(ATP) channels. Am J Physiol Heart Circ Physiol 2001; 280:H2321-8
225. Riess ML, Camara AK, Novalija E, Chen Q, Rhodes SS, Stowe DF: Anesthetic preconditioning attenuates mitochondrial Ca2+ overload during ischemia in guinea pig intact hearts: Reversal by 5-hydroxydecanoic acid. Anesth Analg 2002; 95:1540-6
226. Siegmund B, Schlack W, Ladilov YV, Balser C, Piper HM: Halothane protects cardiomyocytes against reoxygenation-induced hypercontracture. Circulation 1997; 96:4372-9
227. 2+ release in rat ventricular myocytes. ANESTHESIOLOGY 2000; 93:1034-44
228. Zucchi R, Ronca F, Ronca-Testoni S: Modulation of sarcoplasmic reticulum function: A new strategy in cardioprotection? Pharmacol Ther 2001; 89: 47-65
229. Piper HM, Meuter K, Schafer C: Cellular mechanisms of ischemia-reperfusion injury. Ann Thorac Surg 2003; 75:S644-8
230. Yellon DM, Dana A: The preconditioning phenomenon: A tool for the scientist or a clinical reality? Circ Res 2000; 87:543-50
231. Kloner RA, Jennings RB: Consequences of brief ischemia: Stunning, preconditioning, and their clinical implications: II. Circulation 2001; 104:3158-67
232. Deutsch E, Berger M, Kussmaul WG, Hirshfeld JW Jr, Herrmann HC, Laskey WK: Adaptation to ischemia during percutaneous transluminal coronary angioplasty: Clinical, hemodynamic, and metabolic features. Circulation 1990; 82:2044-51
233. Laskey WK: Beneficial impact of preconditioning during PTCA on creatine kinase release. Circulation 1999; 99:2085-9
234. Leesar MA, Stoddard M, Ahmed M, Broadbent J, Bolli R: Preconditioning of human myocardium with adenosine during coronary angioplasty. Circulation 1997; 95:2500-7
235. Saito S, Mizumura T, Takayama T, Honye J, Fukui T, Kamata T, Moriuchi M, Hibiya K, Tamura Y, Ozawa Y: Antiischemic effects of nicorandil during coronary angioplasty in humans. Cardiovasc Drugs Ther 1995; 9(suppl 2):257-63
236. Sakai K, Yamagata T, Teragawa H, Matsuura H, Chayama K: Nicorandil-induced preconditioning as evidenced by troponin T measurements after coronary angioplasty in patients with stable angina pectoris. Jpn Heart J 2002; 43:443-53
237. Okazaki Y, Kodama K, Sato H, Kitakaze M, Hirayama A, Mishima M, Hori M, Inoue M: Attenuation of increased regional myocardial oxygen consumption during exercise as a major cause of warm-up phenomenon. J Am Coll Cardiol 1993; 21:1597-604
238. Marber MS, Joy MD, Yellon DM: Is warm-up in angina ischaemic preconditioning? Br Heart J 1994; 72:213-5
239. Yellon DM, Alkhulaifi AM, Pugsley WB: Preconditioning the human myocardium. Lancet 1993; 342:276-7
240. Jenkins DP, Pugsley WB, Alkhulaifi AM, Kemp M, Hooper J, Yellon DM: Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. Heart 1997; 77:314-8
241. Wu ZK, Tarkka MR, Pehkonen E, Kaukinen L, Honkonen EL, Kaukinen S: Ischaemic preconditioning has a beneficial effect on left ventricular haemodynamic function after a coronary artery biopass grafting operation. Scand Cardiovasc J 2000; 34:247-53
242. Wu ZK, Tarkka MR, Pehkonen E, Kaukinen L, Honkonen EL, Kaukinen S: Beneficial effects of ischemic preconditioning on right ventricular function aftercoronary artery bypass grafting. Ann Thorac Surg 2000; 70:1551-7
243. Wu ZK, Iivainen T, Pehkonen E, Laurikka J, Tarkka MR: Ischemic preconditioning suppresses ventricular tachyarrhythmias after myocardial revascularization. Circulation 2002; 106:3091-6
244. Laurikka J, Wu ZK, Iisalo P, Kaukinen L, Honkonen EL, Kaukinen S, Tarkka MR: Regional ischemic preconditioning enhances myocardial performance in off-pump coronary artery bypass grafting. Chest 2002; 121:1183-9
245. Kaukoranta PK, Lepojarvi MP, Ylitalo KV, Kiviluoma KT, Peuhkurinen KJ: Normothermic retrograde blood cardioplegia with or without preceding ischemic preconditioning. Ann Thorac Surg 1997; 63:1268-74
246. Cremer J, Steinhoff G, Karck M, Ahnsell T, Brandt M, Teebken OE, Hollander D, Haverich A: Ischemic preconditioning prior to myocardial protection with cold blood cardioplegia in coronary surgery. Eur J Cardiothorac Surg 1997; 12:753-8
247. Cremer J, Karck M, Ahnsel T, Steinhoff G, Brandt M, Hollander D, Teebken O, Zick G, Haverich A: Ischemic preconditioning as an adjunct to crystalloid or blood cardioplegia for myocardial protection in routine coronary surgery. Thorac Cardiovasc Surg 1998; 46(suppl 2):298-301
248. Carroll R, Yellon DM: Delayed cardioprotection in a human cardiomyocyte-derived cell line: The role of adenosine, p38MAP kinase and mitochondrial KATP. Basic Res Cardiol 2000; 95:243-9
249. Tarnow J, Markschies-Homung A, Schulte-Sasse U: Isoflurane improves the tolerance to pacing-induced myocardial ischemia. ANESTHESIOLOGY 1986; 64: 147-56
250. Belhomme D, Peynet J, Louzy M, Launay JM, Kitakaze M, Menasche P: Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation 1999; 100(suppl 19):II340-4
251. Haroun-Bizri S, Khoury SS, Chehab IR, Kassas CM, Baraka A: Does isoflurane optimize myocardial protection during cardiopulmonary bypass? J Cardiothorac Vasc Anesth 2001; 15:418-21
252. Penta de Peppo A, Polisca P, Tomai F, De Paulis R, Turani F, Zupancich E, Sommariva L, Pasqualetti P, Chiariello L: Recovery of IV contractility in man is enhanced by preischemic administration of enflurane. Ann Thorac Surg 1999; 68:112-8
253. De Hert SG, ten Broecke PW, Mertens E, Van Sommeren EW, De Blier IG, Stockman BA, Rodrigus IE: Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. ANESTHESIOLOGY 2002; 97:42-9
254. Conzen PF, Fischer S, Detter C, Peter K: Sevoflurane provides greater protection of the myocardium than propofol in patients undergoing off-pump coronary artery bypass surgery. ANESTHESIOLOGY 2003; 99:826-33
255. De Hert SG, Cromheecke S, ten Broecke PW, Mertens E, De Blier IG, Stockman BA, Rodrigus IE, Van der Linden PJ: Effects of propofol, desfluRane, and sevoflurane on recovery of myocardial function after coronary surgery in elderly high-risk patients. ANESTHESIOLOGY 2003; 99:314-23
256. Julier K, da Silva R, Garcia C, Bestmann L, Frascarolo P, Zollinger A, Chassot PG, Schmid ER, Turina MI, von Segesser LK, Pasch T, Spahn DR, Zaugg M: Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: A double-blinded, placebo-controlled, multicenter study. ANESTHESIOLOGY 2003; 98:1315-27
257. Pouzet B, Lecharny JB, Dehoux M, Paquin S, Kitakaze M, Mantz J, Menasche P: Is there a place for preconditioning during cardiac operations in humans? Ann Thorac Surg 2002; 73:843-8
258. Warltier DC, Pagel PS, Kersten JR: Approaches to the prevention of perioperative myocardial ischemia. ANESTHESIOLOGY 2000; 92:253-9
259. Van Der Linden PJ, Daper A, Trenchant A, De Hert SG: Cardioprotective effects of volatile anesthetics in cardiac surgery. ANESTHESIOLOGY 2003; 99:516-7
260. Sniecinski R, Liu H: The effect of myocardial function protection of sevoflurane preconditioning in senescent rats (on-line abstract available at: www.anesthesiology.org). ANESTHESIOLOGY 2003; 99:A1548
261. Zaugg M, da Silva R, Sergeev PV, Pasch T, Schaub MC: Unraveling the gene expression patterns in ischemic and anesthetic preconditioning by gene chip analysis (on-line abstract available at: www.anesthesiology.org). ANESTHESIOLOGY 2003; 99:A1544
262. Homi HM, Mixco JM, Sheng H, Grocott HP, Pearlstein RD, Warner DS: Severe hypotension is not essential for isoflurane neuroprotection against forebrain ischemia in mice. ANESTHESIOLOGY 2003; 99:1145-51